OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Kevin Donaghy: When Stage IV Melanoma Changed the Meaning of Hope

Amer Zeidan: Can All-Oral Therapy Reduce the Healthcare Burden for AML Patients?

Adagene Completes Phase 2 Enrollment for Muzastotug Plus Pembrolizumab in MSS Colorectal Cancer

10 Cancer Research Funding Opportunities to Know This November

Lived Experience Advocacy Hub Webinar Opportunity: AI in Oncology

Oncology News, Insights, Stories by OncoDaily

Boston
Not To Miss

Save the Date: Boston Will Become a Meeting Place for the Future of GI Oncology

GU Oncology
Genitourinary Oncology

10 Must-Read Posts in GU Oncology This Week

Marina Chiara Garassino
Science

Marina Chiara Garassino Highlights Five-Year Follow-Up Results From the KEYNOTE-671 Trial in Resectable NSCLC

Mohammad Al Nahedh Takes On Role of Oncology Medical Head at Novartis

Skin After Radiation Therapy: Burns, Healing Stages, and Care

European Commission Expands Melphalan Flufenamide Approval to Third-Line Treatment for Multiple Myeloma

10 Must-Read Posts in GI Oncology This Week

Lived Experience Advocacy Hub Webinar Opportunity: AI in Oncology

Genmab’s Phase 3 LiGeR-HN1 Trial Met Primary Endpoints of Overall Survival and Response Rate in HNSCC

Supermodel Lara Stone Reveals Breast Cancer Diagnosis at 42

Voices
 Emad Shash

Emad Shash: NCI BGO 2026 - Everything I Believe Modern Oncology Should Represent

Mohamed Abazeed: What Opportunities Does AI Create for the Future of Medicine?

Sandra Demaria: Who Is Shaping the Future of Cancer Immunotherapy at SITC 2026?

Michael McNeil: Highlighting St. Jude Global Colleagues Ahead of the Half Marathon

Stacey Tinianov on the National Cancer Policy Summit: From Presentations to Practice

Doug Hawkins: Grateful for the Honored Guests at the Jeffrey Pride Foundation

Emad Shash: BCCC Welcomes International Colleagues Ahead of AfSMAC26

FDA Approvals
Amivantamab

After a Decade Without a New Option, FDA Approves Amivantamab for Head and Neck Cancer

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

ACCC Oncology Reimbursement Meeting - Providence

Association of Cancer Care Centers (ACCC)

10 Nov
ACCC Oncology

ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona

European Society For Medical Oncology (ESMO)

11 Nov
Brain Metastases

44th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow

Physicians’ Education Resource

11 Nov
44th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow

AACR Frontiers in Cancer Science 2026

American Association for Cancer Research

11 Nov
Cancer Science 2026

The AONN+ Annual Navigation and Survivorship Conference 2026

Academy of Oncology Nurse & Patient Navigators (AONN+)

11 Nov
AONN+

The Milken Institute Future of Health Summit 2026

Milken Institute

11 Nov
Future of Health Summit

SPCC Webinar: Real-World AI and Human–AI Collaboration in Oncology

Sharing Progress in Cancer Care (SPCC)

11 Nov
SPCC

ASCO Oncology Training Program Leadership Retreat

American Society of Clinical Oncology (ASCO)

12 Nov
Oncology Training Program, ASCO

The 31st Annual Meeting and Education Day of the Society for Neuro-Oncology - SNO 2026

Society for Neuro-Oncology (SNO)

12 Nov
Society for Neuro-Oncology

The ITMIG and LALCA26 Joint Conference

IASLC Latin America Conference on Lung Cancer (LALCA)

12 Nov
LALCA26

AACR-KCA Joint Conference on Precision Medicine in Cancer

American Association for Cancer Research (AACR)

12 Nov
AACR-KCA Joint Conference

Mayo Clinic Cardio-Oncology Update 2026

Mayo Clinic

12 Nov
Cardio-Oncology Update

Immune-oncology
PD-L1: One Biomarker, Three Different Scores

PD-L1: One Biomarker, Three Different Scores

NEO-CESQ Trial: Can Molecular Biomarkers Predict Recurrence After Immunotherapy?

Professor Gianluca Franceschini on Surgical De-escalation: Rethinking Breast Surgery in the Immunotherapy Era

10 Must-Read Posts in Immuno-Oncology This Week

Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment

KEYFORM-007: Dual PD-1/LAG-3 Blockade in MSS Colorectal Cancer

Agentic AI for Immune-Related Adverse Event Detection in Cancer Immunotherapy

Gastrointestinal-Oncology
Muzastotug

Adagene Completes Phase 2 Enrollment for Muzastotug Plus Pembrolizumab in MSS Colorectal Cancer

10 Must-Read Posts in GI Oncology This Week

UNICORN Phase 2: Neoadjuvant Botensilimab Plus Balstilimab Shows Promising Activity in pMMR and dMMR Colon Cancer

Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer

ABC-06 Trial: Prognostic Tumour Markers and Quality of Life With Second-Line FOLFOX in Advanced BTC

PRECEDE Study: Pancreatic Imaging Findings During Surveillance in BRCA1, BRCA2, ATM, and PALB2 Heterozygotes

Advanced Biliary Tract Cancer: Real-World Outcomes of First-Line Chemoimmunotherapy and Subsequent Targeted Therapy

Breast-Oncology
Pembrolizumab

Pembrolizumab Achieves 70.8% Pathological Complete Response in Early TNBC: French Real-World Study Examines Treatment Delivery and Safety

ESMO 2026 Reshapes Metastatic Breast Cancer Treatment: ADCs Move Into First Line as Biomarkers Guide New Strategies

DESTINY-Breast09 Redefines First-Line HER2-Positive Breast Cancer: Balancing Efficacy, Safety, and Treatment Selection

From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer

Neoadjuvant Carboplatin Improves Event-Free Survival in Early TNBC: Pooled Analysis of Three Randomized Trials Strengthens the Evidence

SABCS 2026: The Top 10 Breast Cancer Studies to Watch for Potential Practice-Changing Results

Trastuzumab Deruxtecan Secures EU Approval for Residual HER2-Positive Early Breast Cancer Following DESTINY-Breast05 Survival-Free Disease Benefit

Lung-Oncology
HERON-Lung01

HERON-Lung01: Ruzaltatug Rezetecan Reduces Progression Risk in EGFR-Mutated NSCLC Following EGFR-TKI Therapy

SABR Versus Surgery in Early-Stage NSCLC: New JCO Study Supports Surgical Resection, With Important Questions for Older Patients

Small Cell Lung Cancer in Algeria in 2026: A Chemosensitive Disease That Leaves Little Room for Delay

Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR

LungÕ 2026: Integrating Care and Advancing Treatment for Locally Advanced Lung Cancer

Tarlatamab-Associated Neurotoxicity in SCLC: New Study Identifies TIAN in Patients With Brain Metastases

Neoadjuvant Immunotherapy Linked to Improved Five-Year Survival in Resected NSCLC: Real-World Study Supports Long-Term Benefit Without Increased Surgical Morbidity

OncoDaily TV
Dr Gevorg Tamamyan

Dr Gevorg Tamamyan Welcomes Prof Cesaltina Lorenzoni, President of AORTIC, to the International Advisory Board of WHO Director-General Campaign

Dr Gevorg Tamamyan

Mongolia’s Former Minister of Health Dr Chinburen Jigjidsuren Will Join the International Advisory Board of Dr Gevorg Tamamyan’s WHO DG Campaign

Rachel Purcell

Rachel Purcell Highlights New Zealand’s Nationwide Exercise Program for Bowel Cancer Patients

Alicia Fong

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Not To Miss
Boston

Save the Date: Boston Will Become a Meeting Place for the Future of GI Oncology

Adagene Completes Phase 2 Enrollment for Muzastotug Plus Pembrolizumab in MSS Colorectal Cancer

European Commission Expands Melphalan Flufenamide Approval to Third-Line Treatment for Multiple Myeloma

The AstraZeneca Foundation Awards Over $1.1 Million to Expand Community Healthcare Access

Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer

LungÕ 2026: Global Experts Examine the Changing Landscape of Lung Cancer Care

SIOG 2026: 15 Posts Not to Miss from the Annual Conference in Valencia

OncoGrants
Gilead Research Scholars Program

Gilead Research Scholars Program 2026–2027

Breast Cancer Research

Pfizer Atirmociclib Breast Cancer Research Grants 2027: $8 Million Funding Pool

Allied World–St. Baldrick’s Survivorship

Allied World–St. Baldrick’s Survivorship and Supportive Care Research Grant 2027

Blood Cancer UK

Blood Cancer UK PhD Studentships 2026–2027

Regenerative Cancer Medicine Award

AACR Bosarge–Waun Ki Hong Regenerative Cancer Medicine Award 2027

Research Fellowship

Arthur Child Cancer Centre Lung Cancer Clinical and Research Fellowship

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Donjeta Bali Alia

Donjeta Bali Alia

Oncologists Location Tirana, Albania
Sara Lonardi

Sara Lonardi

Oncologists Location Padua, Italy
Alexandra Müller

Alexandra Müller

Oncologists Location Freiburg, Germany
Kleida Mati

Kleida Mati

Oncologists Location Tirana, Albania
David Kerr

David Kerr

Oncologists Location
Wade Swenson

Wade Swenson

Oncologists Location Staples, USA
Nermean Mostafa

Nermean Mostafa

Oncologists Location Cairo, Egypt
Dragana Stanić Tišma

Dragana Stanić Tišma

Oncologists Location Belgrade, Serbia

Drugs Atlas
Isatuximab (Sarclisa, Sarclisa Escena): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Isatuximab-irfc (Sarclisa, Sarclisa Escena) Nov 8, 2026 1:29 am
Daratumumab (Darzalex, Darzalex Faspro): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Daratumumab (Darzalex, Darzalex Faspro) Nov 8, 2026 1:28 am
Bevacizumab (Avastin): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Bevacizumab (Avastin) Nov 6, 2026 4:49 pm
Panitumumab (Vectibix): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Panitumumab (Vectibix) Nov 5, 2026 1:18 pm
Cetuximab (Erbitux): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Cetuximab (Erbitux) Nov 5, 2026 1:14 pm
Margetuximab (Margenza): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Margetuximab (Margenza) Nov 5, 2026 1:09 pm
Pertuzumab (Perjeta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Pertuzumab (Perjeta) Nov 3, 2026 9:23 am
Trastuzumab (Herceptin): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Trastuzumab (Herceptin) Nov 2, 2026 5:11 pm
Ofatumumab (Arzerra, Kesimpta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Ofatumumab (Arzerra, Kesimpta) Nov 1, 2026 1:25 am
Obinutuzumab (Gazyva): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Obinutuzumab (Gazyva; Gazyvaro) Nov 1, 2026 1:23 am

OncoDaily Magazine

New Paper Alert
Luciano Costa

Luciano Costa: The “BALI” Strategy for Preventing Infections in Multiple Myeloma Patients

Gilberto Lopes

Gilberto Lopes: New Research Reveals Elevated Long-Term Heart Risks in Young Cancer Survivors

Pavlos Msaouel

Pavlos Msaouel: Introducing RMC-COMPASS for RMC Risk Assessment

Ted Yanagihara

Ted Yanagihara: Assessing the Impact of PROSPECT and ESOPEC on GI Radiation Treatment Patterns

Aung Naing

Aung Naing: Reflecting on the Immune Checkpoint Inhibitor Journey and Its Impact on Patient Care

Kim Nichols

Kim Nichols Shares New Guideline on Genetic Testing for Childhood Cancer Survivors

OncoDaily Medical Journal

GU Oncology

10.69690/ODMJ-001-1026-8269

Psychosocial burden and lifestyle impact in patients with renal cell carcinoma: a patient-reported outcomes analysis
Original Research

Pediatric Oncology

10.69690/ODMJ-001-1026-8309

Limited Prognostic Value of Baseline Curie Score in Children with High-Risk Neuroblastoma Treated with Contemporary Multi-modal Therapy: A Single-Center Retrospective Cohort Study
Original Research

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews